share_log

启明医疗-B(02500.HK)接获联交所复牌指引

Kai Ming Medical-B (02500.HK) receives guidance on the resumption of trading from the Stock Exchange

Gelonghui Finance ·  Dec 27, 2023 05:19

Gelonghui, December 27 | Qiming Medical-B (02500.HK) announced that on December 20, 2023, the company received a letter from the Stock Exchange setting out the guidelines for resuming trading of the company's shares (collectively referred to as the resumption guidelines). According to the resumption guidelines, the company shall: (a) conduct a special review and conduct an appropriate supervisory investigation with respect to (a) the provision of loans to Mr. Zi and Mr. Tsang and (b) other financial flows that may be discovered during the special review between the Group and Mr. Zi, Mr. Tsang and/or any entity owned or controlled by them alone or jointly; (b) conduct an independent internal control review to prove that the company has established sufficient internal controls and procedures to comply with the listing rules; (c) prove the integrity of management and/or any person having a significant influence on the management and operation of the company Honesty, there are no reasonable regulatory concerns that pose a risk to investors and damage market confidence; and (d) disclosing all material information to the market for shareholders and investors to assess the company's situation.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment